FMC Q1 net loss $281M, Adj EBITDA $72M above guidance; reaffirms FY outlook

FMC CORP

2026-Q1 EPS reported -$2.25 revenue$758,600,000

Revenue $759M (-4% YoY); GAAP EPS $(2.25); adj EPS $(0.23); adj EBITDA $72M (-40%).
Board-authorized strategic alternatives evaluation (since Feb 2026) progressing; no transaction assured.
FY 2026 guidance reaffirmed: rev $3.6-3.8B, adj EBITDA $670-730M, adj EPS $1.63-1.89, FCF -$65M to $65M.
Q2 2026 view: rev $850-900M, adj EBITDA $130-150M, adj EPS $0.16-0.26.
New active ingredient sales doubled YoY; Plant Health grew 6%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

FMC CORP reported full-year 2026 results: revenue $3.60 billion to $3.80 billion, EPS $1.63 to $1.89. Guidance reaffirmed.

Period: full-year 2026
Revenue: $3.60 billion to $3.80 billion
EPS: $1.63 to $1.89
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

diluted share, down $2.13 versus Q1 2025 • Adjusted loss per diluted share of $0.23, down 41 cents versus Q1 2025 Maintains 2026 Full-Year Outlook 1 • Revenue excluding India of $3.60 billion to $3.80 billion, a decline of 5 percent at the midpoint versus 2025 ◦ Excluding 2025 India contributions the 2026 outlook represents a decline at the midpoint of 3 percent •

View on SEC.gov

580 earnings releases filed in the last 30 days. Browse all earnings releases →

FMC CORP filing history →

Source: SEC EDGAR

accession 0000037785-26-000083

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.